ClinicalTrials.gg
Drug

Sonidegib clinical trials

Also written LDE225, Odomzo and Erismodegib.

studies test it
40
open now
1
in phase 3
0
first study started
2009

How each study uses sonidegib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sonidegib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Jul 2015 · ODOMZO · NDA 205266 (FDA, Drugs@FDA)
European Union
14 Aug 2015 · Odomzo · EMEA/H/C/002839 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sonidegib
15
Smoothened Antagonist LDE225
4

Brand

Odomzo
6

Development codes

LDE225
29

Other names

Erismodegib
6

Studies by the year they started

40 studies that test it; most in 2014 (12)

Studies that test sonidegib, by start year
YearStudies
20092
20101
20115
20126
20136
201412
20152
20181
20201
20211
20221
20231
20241

Who runs them

Industry 16 · Other 24

Novartis Pharmaceuticals (15) · Mayo Clinic (3) · Massachusetts General Hospital (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · Anne Chang (2) · Gruppo Oncologico del Nord-Ovest (1) · University of Alabama at Birmingham (1) · Jemincare (1)

Often tested with

Tested in the same studies.

Buparlisib (2) · Irinotecan (2) · Gemcitabine (1) · Ribociclib (1) · Trametinib (1) · Filgrastim (1) · Fluorouracil (1) · Leucovorin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test sonidegib.

Studies

Open first, then newest update. How each study uses sonidegib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 40

See all 40 studies that test sonidegib →

Given beside what is tested · 1 — sonidegib is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with sonidegib

Codes

What other systems call sonidegib · ClinicalTrials.gg INT005894

  • MeSH (NLM) C561435sonidegibOne source NLM
  • UNII (FDA) 0RLU3VTK5MSONIDEGIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1659191Confirmed FDA, Wikidata
  • Wikidata Q22075856sonidegibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C82385SonidegibOne source FDA
  • DrugBank DB09143One source Wikidata

Also registered as sonidegib phosphate (UNII W421AI34UW · RxNorm 1659192).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.